Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings

Background/Objectives: This study aimed to reappraise the practice of treating admission-day blood values as a fixed baseline in sudden sensorineural hearing loss (SSNHL). Blood markers were grouped into clinical axes A (acute cellular stress), B (reserve/protein), and C (acute-phase response) and tested for associations with onset, baseline pure-tone average (PTA), and recovery at timings E0, Eb, and Δ. Methods: First SSNHL episodes were identified in a single-center OMOP CDM (n = 5311; 2002–2025). Markers were classified into three clinical axes (A/B/C), and sampling timing was separated into E0, Eb, and Δ. Prespecified hypotheses were H1 (onset OR for Eb 36-month NLR, TP, and Glb), H2 (E0 albumin–PTA), and H3 (E0 CAR–PTA). Onset used 1:4 age–sex matched odds ratios; PTA used linear regression; recovery used logistic regression. Exploratory analyses were controlled with Benjamini–Hochberg FDR. Recovery sensitivity definitions and indication-stratified rematching were applied. Results: Under H1, onset ORs were NLR 1.05 (1.03–1.07), TP 0.81 (0.73–0.90), and Glb 0.83 (0.73–0.95). Under H2, E0 albumin–PTA β was −12.94 (−17.49 to −8.40; q < 0.001). Under H3, E0 CAR–PTA β was 6.88 (1.61–12.15; q = 0.039). E0 NLR was unrelated to PTA. Recovery remained null after definition diversification and FDR. After indication-stratified rematching, the NLR onset OR and E0 albumin/CAR–PTA signals were retained. Conclusions: SSNHL blood markers should be reported by clinical axis (A/B/C) and sampling timing (E0/Eb/Δ). Onset and baseline-severity signals persist after indication adjustment, whereas evidence for recovery prediction remains weak.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2026-11-18
DOI
https://doi.org/10.3390/diagnostics16223843
Primary Topic
Vestibular and auditory disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings

Chul Young Yoon, 윤담, Young Joon Seo, Songyi Kim et al.
2 links
Diagnostics
Vestibular and auditory disorders
article

Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings

Chul Young Yoon, 윤담, Young Joon Seo, Songyi Kim, Jin Su Kim, Seungmi Im, Yeon Ho Seo
article en

Abstract

Background/Objectives: This study aimed to reappraise the practice of treating admission-day blood values as a fixed baseline in sudden sensorineural hearing loss (SSNHL). Blood markers were grouped into clinical axes A (acute cellular stress), B (reserve/protein), and C (acute-phase response) and tested for associations with onset, baseline pure-tone average (PTA), and recovery at timings E0, Eb, and Δ. Methods: First SSNHL episodes were identified in a single-center OMOP CDM (n = 5311; 2002–2025). Markers were classified into three clinical axes (A/B/C), and sampling timing was separated into E0, Eb, and Δ. Prespecified hypotheses were H1 (onset OR for Eb 36-month NLR, TP, and Glb), H2 (E0 albumin–PTA), and H3 (E0 CAR–PTA). Onset used 1:4 age–sex matched odds ratios; PTA used linear regression; recovery used logistic regression. Exploratory analyses were controlled with Benjamini–Hochberg FDR. Recovery sensitivity definitions and indication-stratified rematching were applied. Results: Under H1, onset ORs were NLR 1.05 (1.03–1.07), TP 0.81 (0.73–0.90), and Glb 0.83 (0.73–0.95). Under H2, E0 albumin–PTA β was −12.94 (−17.49 to −8.40; q < 0.001). Under H3, E0 CAR–PTA β was 6.88 (1.61–12.15; q = 0.039). E0 NLR was unrelated to PTA. Recovery remained null after definition diversification and FDR. After indication-stratified rematching, the NLR onset OR and E0 albumin/CAR–PTA signals were retained. Conclusions: SSNHL blood markers should be reported by clinical axis (A/B/C) and sampling timing (E0/Eb/Δ). Onset and baseline-severity signals persist after indication adjustment, whereas evidence for recovery prediction remains weak.

DiagnosticsVol. 16(22)
Yonsei University (KR)
Ministry of Education - Singapore, Korea Research Institute of Standards and Science, National Research Foundation of Korea, Korea Evaluation Institute of Industrial Technology
Good health and well-being
Vestibular and auditory disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon